Publication: Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial
Issued Date
2008-09-01
Resource Type
ISSN
00359203
Other identifier(s)
2-s2.0-48349140001
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.102, No.9 (2008), 861-867
Suggested Citation
Md Mushfiqur Rahman, Arjen M. Dondorp, Nicholas P.J. Day, Niklas Lindegardh, Mallika Imwong, M. A. Faiz, A. Mannan Bangali, A. T.M.Mustafa Kamal, Jahirul Karim, Jaranit Kaewkungwal, Pratap Singhasivanon Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.102, No.9 (2008), 861-867. doi:10.1016/j.trstmh.2008.05.022 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/19298
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial
Abstract
As artemether/lumefantrine is now deployed as the first-line treatment for uncomplicated falciparum malaria in Bangladesh, information on its efficacy and adherence to its use is important. A randomised controlled non-inferiority trial comparing directly observed treatment (DOT) and non-directly observed treatment (NDOT) was conducted in 320 patients with uncomplicated falciparum malaria in Bandarban Hill Tract District, Bangladesh. Both regimens showed similar high levels of PCR-corrected 42-day parasitological and clinical cure rates (99.3% in the NDOT group and 100% in the DOT group; P = 0.49). Survival analysis for the time to recurrence of infection showed no difference between treatment groups (log rank, P = 0.98). Adherence, as assessed by counting remaining tablets and oral interviews, was 93% in the NDOT group and was confirmed by Day 7 lumefantrine concentrations. Adherence was independent of educational level. Patients with plasma lumefantrine concentrations <280 ng/ml at Day 7 were at greater risk for re-infection (relative risk 5.62; P = 0.027). The efficacy of artemether/lumefantrine for the treatment of uncomplicated falciparum malaria in Bangladesh is high and is similar for DOT and NDOT. Adherence to therapy is high. © 2008 Royal Society of Tropical Medicine and Hygiene.